
News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Method Validation by Phase of Development: An Acceptable Analytical Practice
This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.
Advertisement
Articles in this issue
almost 22 years ago
Still Waiting for Answersalmost 22 years ago
Comparing and Contrasting Barrier Isolator Decontamination Systemsalmost 22 years ago
November 2004almost 22 years ago
In the Spotlight-November 2004almost 22 years ago
Searching for a Viable Business Modelalmost 22 years ago
FDA Moves To Implement New GMP PoliciesAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
4
CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda
5




